Cargando…
Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
BACKGROUND: Our previous proteomic study indicated that connective tissue growth factor (CTGF) may be a potential biomarker for rheumatoid arthritis (RA) diagnosis. The aim was to assess the performance of CTGF as a biomarker of RA. METHOD: Serum and synovial fluid CTGF was detected using a direct h...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700625/ https://www.ncbi.nlm.nih.gov/pubmed/29166915 http://dx.doi.org/10.1186/s13075-017-1463-1 |
_version_ | 1783281162604511232 |
---|---|
author | Yang, Xinyu Lin, Ke Ni, Shanmin Wang, Jianmin Tian, Qingqing Chen, Huaijun Brown, Matthew A. Zheng, Kaidi Zhai, Weitao Sun, Li Jin, Shengwei Wang, Jianguang |
author_facet | Yang, Xinyu Lin, Ke Ni, Shanmin Wang, Jianmin Tian, Qingqing Chen, Huaijun Brown, Matthew A. Zheng, Kaidi Zhai, Weitao Sun, Li Jin, Shengwei Wang, Jianguang |
author_sort | Yang, Xinyu |
collection | PubMed |
description | BACKGROUND: Our previous proteomic study indicated that connective tissue growth factor (CTGF) may be a potential biomarker for rheumatoid arthritis (RA) diagnosis. The aim was to assess the performance of CTGF as a biomarker of RA. METHOD: Serum and synovial fluid CTGF was detected using a direct high sensitivity sandwich ELISA kit. Serum CTGF levels were tested for discriminatory capacity and optimal assay cutoffs determined in a training cohort of 98 cases of RA with 103 healthy controls. The assay performance was then validated in a further cohort of 572 patients (with RA (n = 217), ankylosing spondylitis (n = 92), gout (n = 74), osteoarthritis (n = 52), systemic lupus erythematosus (n = 72), or primary Sjögren’s syndrome (pSS) (n = 65)). RESULTS: Significant elevation of synovial fluid CTGF concentration was found in RA patients, demonstrating excellent diagnostic ability to predict RA (area under the curve (AUC) = 0.97). Similar results were found in serum CTGF detection. At the optimal cutoff value 88.66 pg/mL, the sensitivity, specificity, and the AUC was 0.86, 0.92, and 0.92, respectively, in the training cohort. Similar performance was observed in the validation cohort, with sensitivity, specificity, positive likelihood, and negative likelihood of 0.82, 0.91, 5.74, and 0.12, respectively. Stronger discriminatory capacity was seen with the combination of CTGF and anti-citrullinated protein antibody (ACPA) (AUC = 0.96) than with either ACPA or rheumatoid factor (RF) alone (AUC = 0.80 or 0.79, respectively). The discriminatory performance of serum CTGF was consistent across all inflammatory conditions tested (AUC >0.92 in all cases), with the sole exception of pSS. Serum CTGF did not vary with symptom duration or disease activity. CONCLUSIONS: Serum CTGF is a promising diagnostic biomarker for RA, with performance in the current study better than either ACPA or RF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1463-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5700625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57006252017-12-01 Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis Yang, Xinyu Lin, Ke Ni, Shanmin Wang, Jianmin Tian, Qingqing Chen, Huaijun Brown, Matthew A. Zheng, Kaidi Zhai, Weitao Sun, Li Jin, Shengwei Wang, Jianguang Arthritis Res Ther Research Article BACKGROUND: Our previous proteomic study indicated that connective tissue growth factor (CTGF) may be a potential biomarker for rheumatoid arthritis (RA) diagnosis. The aim was to assess the performance of CTGF as a biomarker of RA. METHOD: Serum and synovial fluid CTGF was detected using a direct high sensitivity sandwich ELISA kit. Serum CTGF levels were tested for discriminatory capacity and optimal assay cutoffs determined in a training cohort of 98 cases of RA with 103 healthy controls. The assay performance was then validated in a further cohort of 572 patients (with RA (n = 217), ankylosing spondylitis (n = 92), gout (n = 74), osteoarthritis (n = 52), systemic lupus erythematosus (n = 72), or primary Sjögren’s syndrome (pSS) (n = 65)). RESULTS: Significant elevation of synovial fluid CTGF concentration was found in RA patients, demonstrating excellent diagnostic ability to predict RA (area under the curve (AUC) = 0.97). Similar results were found in serum CTGF detection. At the optimal cutoff value 88.66 pg/mL, the sensitivity, specificity, and the AUC was 0.86, 0.92, and 0.92, respectively, in the training cohort. Similar performance was observed in the validation cohort, with sensitivity, specificity, positive likelihood, and negative likelihood of 0.82, 0.91, 5.74, and 0.12, respectively. Stronger discriminatory capacity was seen with the combination of CTGF and anti-citrullinated protein antibody (ACPA) (AUC = 0.96) than with either ACPA or rheumatoid factor (RF) alone (AUC = 0.80 or 0.79, respectively). The discriminatory performance of serum CTGF was consistent across all inflammatory conditions tested (AUC >0.92 in all cases), with the sole exception of pSS. Serum CTGF did not vary with symptom duration or disease activity. CONCLUSIONS: Serum CTGF is a promising diagnostic biomarker for RA, with performance in the current study better than either ACPA or RF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1463-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-22 2017 /pmc/articles/PMC5700625/ /pubmed/29166915 http://dx.doi.org/10.1186/s13075-017-1463-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Yang, Xinyu Lin, Ke Ni, Shanmin Wang, Jianmin Tian, Qingqing Chen, Huaijun Brown, Matthew A. Zheng, Kaidi Zhai, Weitao Sun, Li Jin, Shengwei Wang, Jianguang Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis |
title | Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis |
title_full | Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis |
title_fullStr | Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis |
title_full_unstemmed | Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis |
title_short | Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis |
title_sort | serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700625/ https://www.ncbi.nlm.nih.gov/pubmed/29166915 http://dx.doi.org/10.1186/s13075-017-1463-1 |
work_keys_str_mv | AT yangxinyu serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT linke serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT nishanmin serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT wangjianmin serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT tianqingqing serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT chenhuaijun serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT brownmatthewa serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT zhengkaidi serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT zhaiweitao serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT sunli serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT jinshengwei serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis AT wangjianguang serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis |